This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

NCT07304791 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Healthy Participant Study

Interventions

DRUG: BEAM-103
DRUG: Placebo Comparator

Sponsor

Beam Therapeutics Inc.